RSR-13, an allosteric hemoglobin modifier, evaluated in GBM in combination with cranial radiotherapy May 19, 1999 No Comments
Potent, water-soluble paclitaxel analogue in early clinical trials presented by BMS at ASCO meeting May 19, 1999 No Comments
Phase I results for endothelin antagonist discussed at ASCO meeting; phase II trials under way May 19, 1999 No Comments
BASF patents new tyrosine kinase inhibitors for hyperproliferative and angiogenic disorders May 19, 1999 No Comments
Orally active antimetabolite CS-682 well tolerated in patients with refractory solid tumors May 18, 1999 No Comments
Pharmacokinetics of AG-2034 examined in patients; results reported at ASCO meeting May 18, 1999 No Comments
RSS